John Robert Havens

Title: John Robert Havens: Innovator in Oligonucleotide Compositions

Introduction

John Robert Havens is a notable inventor based in Evergreen, Colorado. He has made significant contributions to the field of molecular biology, particularly in the development of oligonucleotide compositions. With a total of 3 patents, his work has advanced the methods used for genomic sequencing applications.

Latest Patents

Havens' latest patents include innovative inventions such as T-enhanced blocking oligonucleotides and baits for improved target enrichment and reduced off-target selection. This invention is directed towards modified oligonucleotide compositions and methods that selectively reduce unwanted nucleic acid contaminants. It also enriches desired nucleic acid targets from complex genomic nucleic acid mixtures, enhancing the efficiency of sequencing applications. The modified oligonucleotide compositions feature one or more modified groups that increase the T of the resultant oligonucleotide composition.

Career Highlights

Throughout his career, John Robert Havens has worked with prominent companies in the biotechnology sector. He has been associated with Integrated DNA Technologies, Inc. and Roche Finance Ltd. His experience in these organizations has contributed to his expertise in the field of oligonucleotide research and development.

Collaborations

Havens has collaborated with notable professionals in his field, including Mark Aaron Behlke and Mirna Jarosz. These collaborations have further enriched his work and contributed to advancements in oligonucleotide technology.

Conclusion

John Robert Havens is a distinguished inventor whose work in oligonucleotide compositions has made a significant impact on genomic sequencing. His innovative patents and collaborations highlight his contributions to the field, showcasing his role as a key figure in molecular biology advancements.